These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 2443111)
21. Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: the importance of adequate heparinization. Okita Y; Takamoto S; Ando M; Morota T; Yamaki F; Matsukawa R; Kawashima Y Circulation; 1997 Nov; 96(9 Suppl):II-376-81. PubMed ID: 9386127 [TBL] [Abstract][Full Text] [Related]
22. Thromboembolic disorders in pregnancy: pathophysiology, diagnosis, and treatment, with emphasis on heparin. Flessa HC; Glueck HI; Dritschilo A Clin Obstet Gynecol; 1974 Dec; 17(4):195-235. PubMed ID: 4615859 [TBL] [Abstract][Full Text] [Related]
23. Selective inhibition of coagulation factors: advances in antithrombotic therapy. Bauer KA Semin Thromb Hemost; 2002 Jun; 28 Suppl 2():15-24. PubMed ID: 12073176 [TBL] [Abstract][Full Text] [Related]
24. Profibrinolytic and anticoagulant properties of the pentosan polysulphate derivative bego 0391. Klöcking HP; Hauptmann J; Richter M Pharmazie; 1991 Jul; 46(7):543-4. PubMed ID: 1723804 [No Abstract] [Full Text] [Related]
25. [Treatment of pure nephrotic syndrome with heparin and heparinoids]. Dueymes JM; Carentz F; Pourrat JP; Conte JJ Nouv Presse Med; 1982 Mar; 11(12):939. PubMed ID: 6174931 [No Abstract] [Full Text] [Related]
27. [Interstitial cystitis--pentosan polysulfate and heparin improve quality of life and symptoms]. Krome's-Hertogenbosch S Aktuelle Urol; 2006 Sep; 37(5):316-20; discussion 318-20. PubMed ID: 17004178 [No Abstract] [Full Text] [Related]
28. Hirudin and thrombosis prophylaxis. Turpie AG Lancet; 1996 Mar; 347(9002):632-3. PubMed ID: 8596373 [No Abstract] [Full Text] [Related]
29. Effect of ultrasound on structure and functional properties of antithrombin III and proteins of PPSB complex. Shkumatov VM; Adzerikho IE; Lesnikovich JA; Cherniavsky EA Biochemistry (Mosc); 2004 Feb; 69(2):195-200. PubMed ID: 15000687 [TBL] [Abstract][Full Text] [Related]
30. New approaches to prevention of deep vein thrombosis. Bergqvist D Thromb Haemost; 1997 Jul; 78(1):684-8. PubMed ID: 9198239 [No Abstract] [Full Text] [Related]
31. Extrinsic pathway--associated activated clotting time for anticoagulation monitoring during cardiopulmonary bypass. Gu YJ; Huyzen RJ; van Oeveren W Anesth Analg; 1996 Aug; 83(2):433. PubMed ID: 8694335 [No Abstract] [Full Text] [Related]
32. Comparative study on the in vitro and in vivo activities of heparinoids derivative investigated on the animal model. Giedrojć J; Klimiuk M; Radziwon P; Kłoczko J; Bielawiec M; Breddin HK J Cardiovasc Pharmacol; 1999 Sep; 34(3):340-5. PubMed ID: 10470990 [TBL] [Abstract][Full Text] [Related]
33. Safety of aprotinin in heparinized and nonheparinized patients. Levy JH J Cardiothorac Vasc Anesth; 2004 Aug; 18(4 Suppl):38S-42S. PubMed ID: 15368205 [No Abstract] [Full Text] [Related]
34. Combined use of aprotinin and a heparin-bonded cardiopulmonary bypass system for aortic aneurysm repair. Gallagher JM; Brown ME; Gasior TA J Cardiothorac Vasc Anesth; 1995 Dec; 9(6):728-30. PubMed ID: 8664469 [No Abstract] [Full Text] [Related]
37. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot. Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293 [TBL] [Abstract][Full Text] [Related]
39. Short report on heparin sensitisation; therapeutic use of thrombocid in patients who have allergic reactions to native heparin. VODOPIVEC M Allerg Asthma (Leipz); 1954 Sep; 3(3):23. PubMed ID: 13220078 [No Abstract] [Full Text] [Related]